BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 2.04.2012

Draft Guidances Relating to the Development of Biosimilar Products; Public Hearing; Request for Comments; Correction

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of March 2, 2012 (77 FR 12853). The document announced a public hearing entitled "Draft Guidances Related to the Development of Biosimilar Products; Public Hearing; Request for Comments" to obtain input on recently issued draft guidances relating to the development of biosimilar products. The document published with an incorrect date for submission of electronic and written comments. This document corrects that error.

Source: Federal Register — Food and Drug AdministrationOpen original release →